BENSALEM, Pa., Sept. 02, 2022 (GLOBE NEWSWIRE) — The law firm of Howard G. Smith is reminding investors that class action lawsuits have been filed on behalf of the shareholders of the following public companies. Investors have until the deadlines set out below to file a lead plaintiff filing.

Investors who experience losses on their investments are advised to contact the law firm of Howard G. Smith to discuss their legal rights in these class action lawsuits at 888-638-4847 or by email at [email protected].

Unity Software Inc. u
Class Period: March 5, 2021 – May 10, 2022
Deadline for lead plaintiff: September 6, 2022

The Complaint alleges that throughout the Class Period, the Defendants made false and/or misleading statements and/or failed to disclose the following: (1) flaws in Unity’s product platform reduced the accuracy of the Company’s machine learning technology; (2) the foregoing would be likely to have a material adverse impact on the Company’s revenues; (3) accordingly, Unity had overstated its commercial and/or financial prospects for 2022; and (4) as a result, the defendants’ positive statements about the Company’s business, operations and prospects were materially misleading and/or lacking a reasonable basis at all relevant times.

Beginning Medical, Inc. AROUND
Class Period: September 15, 2020 – June 13, 2022
Deadline for lead plaintiff: September 6, 2022

The Complaint alleges that during the Class Period, the Defendants made false and/or misleading statements and/or failed to disclose the following: (1) The Defendants “continuously made improvements and updates to Tablo over time since the original release” , which required an additional 510 (k) application; (2) as a result, the Company was unable to conduct a human factors study on an approved device in accordance with FDA protocols; (3) the Company’s inability to conduct the Human Factors study exposed the Company to the possibility of the FDA imposing a “cancel embargo” and marketing suspension, thereby rendering the Company unable to complete the.. .